PATINA: A randomized open label phase III trial to evaluate the efficacy and safety of palbociclib + anti HER2 therapy + endocrine therapy vs anti HER2 therapy + endocrine therapy after induction treatment for hormone receptor positive, HER2-positive metastatic breast cancer
Keyword(s):
2019 ◽
Keyword(s):
2018 ◽
Vol 48
(9)
◽
pp. 855-859
◽
Keyword(s):
Keyword(s):
2021 ◽
Keyword(s):
2019 ◽
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS636-TPS636
Keyword(s):
2021 ◽
Keyword(s):
Keyword(s):